Invited Editorials
Vol. 1 No. 1 (2022)
Is transient ischemic attack a minor stroke?
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Received: 31 March 2022
Accepted: 30 April 2022
Accepted: 30 April 2022
687
Views
0
Downloads
Authors
In the current literature, the utility of transient ischemic attack (TIA) diagnosis is under revision by the scientific community and experts. If initially this term was considered a valid diagnostic category, over the years the definition of TIA has been completely subverted, underlining the scientific lability of this nosological entity [...]
Downloads
Download data is not yet available.
Citations
Easton JD, Johnston SC. Time to retire the concept of transient ischemic attack. JAMA 2022;327:813. DOI: https://doi.org/10.1001/jama.2022.0300
A classification and outline of cerebrovascular diseases II. Stroke 1975;6:564-616. DOI: https://doi.org/10.1161/01.STR.6.5.564
Lioutas VA, Ivan CS, Himali JJ, et al. Incidence of transient ischemic attack and association with long-term risk of stroke. JAMA 2021;325:373. DOI: https://doi.org/10.1001/jama.2020.25071
Giles MF, Rothwell PM. Systematic review and pooled analysis of published and unpublished validations of the
ABCD and ABCD2 transient ischemic attack risk scores. Stroke 2010;41:667-73. DOI: https://doi.org/10.1161/STROKEAHA.109.571174
Weimar C, Benemann J, Michalski D, et al. Prediction of recurrent stroke and vascular death in patients with transient ischemic attack or nondisabling stroke. Stroke 2010;41:487-93. DOI: https://doi.org/10.1161/STROKEAHA.109.562157
Song B, Fang H, Zhao L, et al. Validation of the ABCD 3 -I score to predict stroke risk after transient ischemic attack. Stroke 2013;44:1244-8. DOI: https://doi.org/10.1161/STROKEAHA.113.000969
Brazzelli M, Chappell FM, Miranda H, et al. Diffusionweighted imaging and diagnosis of transient ischemic attack. Ann Neurol 2014;75:67-76. DOI: https://doi.org/10.1002/ana.24026
Yu AYX, Coutts SB. Role of brain and vessel imaging for the evaluation of transient ischemic attack and minor stroke. Stroke 2018;49:1791-5. DOI: https://doi.org/10.1161/STROKEAHA.118.016618
Mendelson SJ, Prabhakaran S. Diagnosis and management of transient ischemic attack and acute ischemic stroke. JAMA 2021;325:1088. DOI: https://doi.org/10.1001/jama.2020.26867
Wang Y, Pan Y, Zhao X, et al. Clopidogrel with aspirin in acute minor stroke or transient ischemic attack (CHANCE) trial. Circulation 2015;132:40-6. DOI: https://doi.org/10.1161/CIRCULATIONAHA.114.014791
Pan Y, Elm JJ, Li H, et al. Outcomes associated with clopidogrel-aspirin use in minor stroke or transient ischemic attack. JAMA Neurol 2019;76:1466. DOI: https://doi.org/10.1001/jamaneurol.2019.2531
How to Cite
1.
Dolcetti E, Bruno A, Centonze D. Is transient ischemic attack a minor stroke?. Bleeding Thromb Vascul Biol [Internet]. 2022 May 12 [cited 2026 Jan. 27];1(1). Available from: https://www.btvb.org/btvb/article/view/31
Copyright (c) 2022 The Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Similar Articles
- Stefania Cavazza, Gualtiero Palareti*, Still unmet problems with low molecular weight heparin prophylaxis of venous thromboembolism. An Italian survey , Bleeding, Thrombosis and Vascular Biology: Vol. 4 No. 3 (2025)
- PO16 | Antithrombotic treatment and outcomes in retinal vein occlusion: a retrospective cohort study and comparison with historical group , Bleeding, Thrombosis and Vascular Biology: Vol. 4 No. s1 (2025)
- Mosaad Almegren, Clinical and radiological characteristics of cerebral vein thrombosis: a retrospective study , Bleeding, Thrombosis and Vascular Biology: Vol. 2 No. 3 (2023)
- CO51 | Novel biomarkers of neurological damage in acute immune-mediated thrombotic thrombocytopenic purpura , Bleeding, Thrombosis and Vascular Biology: Vol. 4 No. s1 (2025)
- CO35 | Bleeding phenotype characterization in patients with congenital bleeding disorders: a multigenic approach using next generation sequencing to identify coagulation-modulating variants , Bleeding, Thrombosis and Vascular Biology: Vol. 4 No. s1 (2025)
- PO24 | Emicizumab prophylaxis and bleeding outcomes: a single center clinical experience , Bleeding, Thrombosis and Vascular Biology: Vol. 4 No. s1 (2025)
- Pantep Angchaisuksiri, Wolfram Ruf, Jeffrey Weitz, Sam Schulman, Guy A. Young, A commitment to global collaboration, welcoming international participation and advancing science for the benefit of patients , Bleeding, Thrombosis and Vascular Biology: Vol. 4 No. 2 (2025)
- Stefania Momi, Giuseppe Guglielmini, Giulia Ciarroca Taranta, Elisa Giglio, Angela Monopoli, Paolo Gresele, A nitric oxide-donor pravastatin hybrid drug exerts antiplatelet and antiatherogenic activity in mice , Bleeding, Thrombosis and Vascular Biology: Vol. 1 No. 2 (2022)
- Luca Barcella, Chiara Ambaglio, Paolo Gritti, Francesca Schieppati, Varusca Brusegan, Eleonora Sanga, Marina Marchetti, Luca Lorini, Anna Falanga, Long-term persistence of high anti-PF4 antibodies titer in a challenging case of AZD1222 vaccine-induced thrombotic thrombocytopenia , Bleeding, Thrombosis and Vascular Biology: Vol. 2 No. 2 (2023)
- Bianca Rocca, Emma Hansson, Milan Milojevic, Anders Jeppsson, 2024 EACTS guidelines on perioperative medication in adult cardiac surgery: embracing precision medicine driven by strong evidence-based methodology , Bleeding, Thrombosis and Vascular Biology: Vol. 4 No. 2 (2025)
You may also start an advanced similarity search for this article.
Most read articles by the same author(s)
- Federica Azzolini, Antonio Bruno, Ettore Dolcetti, Diego Centonze, Fabio Buttari, Tumor necrosis factor superfamily in multiple sclerosis: from pathology to therapeutic implications , Bleeding, Thrombosis and Vascular Biology: Vol. 2 No. 2 (2023)
